Expression of transforming growth factor-β and tumor necrosis factor-α in the plasma and tissues of mice with lupus nephritis

Laboratory Investigation

Volumn 80, Issue 10, 2000, Pages 1561-1570

  Yamamoto, Koji ^a   Loskutoff, David J ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; FIBRINOLYSIS; GENE INDUCTION; GENE LOCATION; INFLAMMATORY CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033784197     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780166     Document Type: Article

References (58)

1. Expression of plasminogen activator inhibitor-1 (PAl-1) during cellular remodeling in proliferative glomerulonephritis in the rat
2. Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans
3. Transforming growth factor β in tissue fibrosis
4. Transforming growth factor-β regulates production of proteoglycans by mesangial cells
5. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
6. Transforming growth factor-β in disease: The dark side of tissue repair
7. Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis
8. Tumor necrosis factor and IL-1 in New Zealand black/white mice. Enhanced gene expression and acceleration of renal injury
9. Transforming growth factor-β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis
10. Intracellular demonstration of active TGFβ1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFβ1 suppresses neutrophil function and host defense against Staphylococcus aureus infection
11. Modulation of endothelial cell hemostatic properties by TNF: Insights into the role of endotheiium in the host response to inflammatory stimuli
12. Transforming growth factor-β production in antiglomerular basement membrane disease in the rabbit
13. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye
14. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis
15. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
16. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
17. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/ tumor necrosis factor from human monocytes
18. Involvement of tumour necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats
19. Active and total TGF-β in human sera, platelets, and plasma
20. Nephropathy of systemic lupus erythematosus
21. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
22. Tumor necrosis factor-α in murine autoimmune 'lupus' nephritis
23. Lupus nephritis with thrombosis and abnormal fibrinolysis: Effect of ancrod
24. Glomerular thrombosis in systemic lupus erythematosus: Prevalence and significance
25. Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis
26. Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue
27. Dysregulated transforming growth factor-beta in neonatal and adult autoimmune MRL-Ipr mice
28. Transforming growth factor-β induction of type 1 plasminogen activator inhibitor
29. Increased release of tumor necrosis factor-α by monocytes from patients with glomerulonephritis
30. Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis
31. Tumor necrosis factor-α is expressed in glomerular visceral epithelial cells in human membranous nephropathy
32. In situ production of TNF-α IL-1β, and IL-2R in ANCA-positive glomerulonephritis
33. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix
34. Plasminogen activator inhibitor-1 is induced in microvascular endothelial cells by a chondrocyte-derived transforming growth factor-beta
35. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction
36. Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type β1
37. Transforming growth factor type-β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
38. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: Induction by tumor necrosis factor-α and lipopolysaccharide
39. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo: Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β
40. Regulation of type I plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: Induction by transforming growth factor-β, lipopolysaccharide, and tumor necrosis factor-α
41. Regulation of endothelial cell coagulant properties: Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor
42. Cytokine activation of vascular endothelium: Effects on tissue-type plasminogen activator and type I plasminogen activator inhibitor
43. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor β
44. Murine models of systemic lupus erythematosus
45. Transforming growth factor beta-1 in acute myocardial infarction in rats
46. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system
47. Genes for IFN-β2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals
48. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target
49. Effects of fibrinogen degradation products on glomerular mesangial cells in culture
50. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo
51. The plasminogen activator/plasmin system
52. Effect of transforming growth factor-β1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells
53. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator
54. The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/ procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis
55. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy
56. Expression of transforming growth factor-β isoforms in human glomerular diseases
57. Biphasic increase in circulating and renal TNF-alpha in MRL-Ipr mice with differing regulatory mechanisms
58. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys